Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2023 | 07-2023 | 04-2023 | 01-2023 | 10-2022 | |
| Operating Expenses | 2,902 | 3,526 | 3,305 | 5,424 | 3,106 |
| Operating Income | -2,902 | -3,526 | -3,305 | -5,424 | -3,106 |
| Interest Expense | 4 | 2 | 1 | 2 | 4 |
| Pre-tax Income | -2,906 | -3,528 | -3,306 | -5,426 | -3,110 |
| Net Income Continuous | -2,906 | -3,528 | -3,306 | -5,426 | -3,110 |
| Net Income | $-2,906 | $-3,528 | $-3,306 | $-5,426 | $-3,110 |
| EPS Basic Total Ops | -39.87 | -48.42 | -47.64 | -74.71 | -43.20 |
| EPS Basic Continuous Ops | -39.85 | -48.38 | -46.37 | -74.50 | -43.07 |
| EPS Diluted Total Ops | -39.87 | -48.42 | -47.64 | -74.71 | -43.20 |
| EPS Diluted Continuous Ops | -39.85 | -48.38 | -46.37 | -74.50 | -43.07 |
| EBITDA(a) | $-2,889 | $-3,513 | $-3,300 | $-5,418 | $-3,101 |